ESR1 and breast carcinoma: Finally, claudin-low are a peculiar group of aggressive breast cancers that are characterized by negative expression of ER, PR, and HER2 (triple-negative), and by the acquisition of mesenchymal/sarcomatoid and/or squamous metaplasia of malignant breast epithelium.